Early, goal-directed mobilization
OtherEarly, goal directed mobilization using (1) the SOMS algorithm and (2) facilitator
NCT Number: NCT03666338
Analysis of the randomized controlled SOMS trial of early, goal-directed mobilization to investigate if the treatment effect is consistent and independent of the initial conscious state without evidence of moderation or modification.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Early, goal directed mobilization using (1) the SOMS algorithm and (2) facilitator
Time frame: At the day of hospital discharge, on average up to 1 month
minimal modified functional independence measure score of 8 (Scale ranging from 0-8 with the subdomain locomotion and transfer 0-4 each)
Time frame: from ICU admission to ICU discharge, on average up to 2 weeks
mean achieved SOMS level
Time frame: At the day of hospital discharge, on average up to 1 month
minimal modified functional independence measure score (range 0-8) of the subdomains transfer and locomotion with 0-4 each
Time frame: Days from ICU admission till first mobilization, approximately up to 5 days
Start to mobilization in days (Surgical Optimal Mobilization Scale > 0, ranging from 0 = no mobilization to 4 ambulation)
Technical University of Munich
Other
Acronym: SOMS-GCS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03431493
Behavior, Behavioral Symptoms
Baltimore, Maryland, United States
View Trial DetailsNCT03789305
Critical Care, Critical Illness
Munich, Bavaria, Germany
View Trial DetailsNCT03628300
Acute Kidney Injury, Beta Lactams
Amiens, France
View Trial DetailsNCT05960994
Critical Care, Intensive Care Units
São Paulo, Brazil
View Trial Details